Skip to content
★ Sign in to follow
CS

Collagen Solutions plc Stock: price and insider trades · United Kingdom

ISIN GB00B94T6Y14GB·

No insider purchase over the last 90 days. The latest, by Brad Selman, was filed 20 Oct 2020.

Collagen Solutions plc: what insiders have been doing

Collagen Solutions plc is a listed company. Filings by its managers are published through RNS (LSE). No insider at Collagen Solutions plc has published a filing in the past twelve months. The most recent one dates from 20 October 2020.

Looking back to 2015, when coverage begins, insiders filed 10 purchases and no sales.

Other companies in the same market with recent insider buying flagged by our signals: CMC Markets plc. This summary is built from RNS (LSE) disclosures alone and does not predict where the share price will go.

Insider Decl.
20
Thresholds
n/a
Buy Volume
€866,764
10 ops. · all time
Sell Volume
n/a
n/a

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Last declaration on 20 October 2020
Declarations20 total
  • ◆
    Chief Financial OfficerExecutives
    0FCA-NSM
    336,000 sharesOutside a trading venueISIN GB00B94T6Y14FCA-NSM:3752755-1
  • ◆
    Chief Executive OfficerExecutives
    168,225 GBP30FCA-NSM
    3,725,000 shares@ £0.0452100.0% of flowOutside a trading venueISIN GB00B94T6Y14FCA-NSM:3752755-0
  • ▲
    PDMR / VP Global Sales and MarketingExecutives
    36,450 GBP34FCA-NSM
    700,000 shares@ £0.0521100.0% of flowOutside a trading venueISIN GB00B94T6Y14FCA-NSM:3752755-2
    Canonical exit: 18 Jan 2021 (T+90)
  • ▲
    PDMR / VP Global R&DExecutives
    55,125 GBP34FCA-NSM
    1,250,000 shares@ £0.0441100.0% of flowOutside a trading venueISIN GB00B94T6Y14FCA-NSM:3752755-3
    Canonical exit: 18 Jan 2021 (T+90)
  • ▲
    PDMR / VP Tissue ProductsExecutives
    57,000 GBP34FCA-NSM
    1,250,000 shares@ £0.0456100.0% of flowOutside a trading venueISIN GB00B94T6Y14FCA-NSM:3752755-4
    Canonical exit: 18 Jan 2021 (T+90)
  • ◆
    Executives
    Executives
    0FCA-NSM
  • ◆
    Executives
    Executives
    0FCA-NSM
  • ◆
    1. Chief Business Officer 2. PDMR / VP Tissue Products 3. PDMR / VP Global R&DExecutives
    75,000 GBP19FCA-NSM
    2,500,000 shares@ £0.03100.0% of flowOutside a trading venueISIN GB00B94T6Y14FCA-NSM:LSE20190711070007_14144298_20200326185124146_26003
  • ●
    1. Non-Executive Director 2. Chief Financial Officer 3. Chief Operating Officer 4. Company SecretaryExecutives
    67,365 GBP27FCA-NSM
    1,497,000 shares@ £0.045100.0% of flowLondon Stock ExchangeISIN GB00B94T6Y14FCA-NSM:LSE20190606095228_14101326_20200326185130043_28066
  • ▲
    ChairmanExecutives
    24,375 GBP19FCA-NSM
    650,000 shares@ £0.03754.6% of flowLondon Stock Exchange, XLONISIN GB00B94T6Y14FCA-NSM:LSE20180925150525_13804133_20200330111446173_4488
    Canonical exit: 24 Dec 2018 (T+90)
  • ◆
    Chief Operating OfficerExecutives
    55,500 GBP19FCA-NSM
    1,500,000 shares@ £0.03791.9% of flowOutside a trading venueISIN GB00B94T6Y14FCA-NSM:LSE20180919170143_13797276_20200330111446712_8984
  • ▲
    Chief Operating OfficerExecutives
    4,999 GBP19FCA-NSM
    115,988 shares@ £0.0431100.0% of flowLondon Stock Exchange, XLONISIN GB00B94T6Y14FCA-NSM:LSE20180903122016_13776755_20200330111447325_22006
    Canonical exit: 2 Dec 2018 (T+90)
  • ▲
    ChairmanExecutives
    86,429 GBP15FCA-NSM
    3,142,857 shares@ £0.0275100.0% of flowLondon Stock ExchangeISIN GB00B94T6Y14FCA-NSM:LSE20180411070004_13599552_20200330111354262_17950
    Canonical exit: 9 Jul 2018 (T+90)
  • ▲
    ChairmanExecutives
    45,900 GBP8FCA-NSM
    900,000 shares@ £0.0519.1% of flowLondon Stock ExchangeISIN GB00B94T6Y14FCA-NSM:LSE20170725113612_13306673_20200330131517604_17988
    Canonical exit: 23 Oct 2017 (T+90)
  • ◆
    1. Chief Executive Officer 2. Chief Financial Officer 3. PDMR / VP Global R&DExecutives
    0FCA-NSM
    3,900,000 sharesOutside a trading venueFCA-NSM:LSE20170713113944_13294159_20200330131517222_9842
  • ◆
    ChairmanExecutives
    335,680 GBP14FCA-NSM
    2,685,437 shares@ £0.12568.8% of flowOutside a trading venueISIN GB00B94T6Y14FCA-NSM:LSE20170327123952_13172609_20200330131526685_21362-0
  • ◆
    Chief Scientific OfficerExecutives
    194,199 GBP19FCA-NSM
    1,553,592 shares@ £0.125100.0% of flowOutside a trading venueISIN GB00B94T6Y14FCA-NSM:LSE20170327123952_13172609_20200330131526685_21362-1
  • ▲
    ChairmanExecutives
    21,748 GBP19FCA-NSM
    434,950 shares@ £0.054.5% of flowLondon Stock ExchangeISIN GB00B94T6Y14FCA-NSM:LSE20170324092654_13170521_20200330131526636_19919
    Canonical exit: 21 Jun 2017 (T+90)
  • ▲
    1. Chairman 2. Chief Executive Officer 3. Chief Financial Officer 4. Non-Executive DirectorExecutives
    380,000 GBP0FCA-NSM
    20,000,000 shares@ £0.019100.0% of flowLondon Stock ExchangeISIN GB00B94T6Y14FCA-NSM:LSE20170307130132_13150131_20200330131526140_5648-0
    Canonical exit: 5 Jun 2017 (T+90)
  • ▲
    Non-Executive DirectorExecutives
    39,484 GBP15FCA-NSM
    438,714 shares@ £0.09100.0% of flowFCA-NSM:LSE20151202154833_012607579_20200330172132053
    Canonical exit: 1 Mar 2016 (T+90)

20 of 20 declarations

About Collagen Solutions plc

Collagen Solutions plc is a company focused on the development and manufacturing of collagen-based solutions for the medical and biopharmaceutical sectors. It is listed on the London Stock Exchange.